facebook
twitter
search
search

J&J receives subpoenas over three drugs

March 12, 2007 at 10:26 AM

NEW BRUNSWICK, N.J., March 12 (UPI) -- Johnson & Johnson said Monday it got subpoenas from three U.S. attorneys' offices related to probes into Risperdal, Topamax and Natrecor.

The subpoenas, which came from the U.S. attorney's offices in Philadelphia, Boston and San Francisco, are associated with investigations into the sales and marketing of Janssen's Risperdal, Ortho-McNeil's Topamax and Scios' Natrecor. All three manufacturers are subsidiaries of Johnson & Johnson.

"The subpoenas request information regarding Johnson and Johnson's corporate supervision and oversight of these three subsidiaries, including their sales and marketing of these drugs," J&J said in a statement.

The company said it will cooperate with the subpoena requests.

Related UPI Stories
Latest Headlines
Trending Stories
Device shown to 'smell' prostate cancer in men in trial
Scientists confirm second, more intense form of Lyme disease
Study: Sending fewer men to prison may slow spread of HIV
Einstein vindicated: Scientists find gravitational waves
Biden gathers forces to end cancer: Can he make a difference?